Back
Cartesian Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28
RNAC
Cartesian Therapeutics, Inc.
Last Price:
$7.43
Seasonality Move:
-8.81%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and RNAC is experiencing slight buying pressure.
Cartesian Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.46 | Buy |
| 20-day SMA: | 6.93 | Buy |
| 50-day SMA: | 7.12 | Buy |
| 200-day SMA: | 9.23 | Sell |
| 8-day EMA: | 6.8 | Buy |
| 20-day EMA: | 4.44 | Buy |
| 50-day EMA: | 2.24 | Buy |
| 200-day EMA: | 0.64 | Buy |
Cartesian Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.13 | Buy |
| Relative Strength Index (14 RSI): | 56.73 | Buy |
| Chaikin Money Flow: | 45343 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.47 - 7.51) | Buy |
| Bollinger Bands (100): | (6.71 - 8.57) | Sell |
Cartesian Therapeutics, Inc. Technical Analysis
| Feb 17 | Feb 18 | Feb 19 | Feb 20 | Feb 23 | Feb 24 | Feb 25 | Feb 26 | Feb 27 | Mar 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cartesian Therapeutics, Inc. Stock
Is Cartesian Therapeutics, Inc. Stock a Buy?
-
Cartesian Therapeutics, Inc. share price is 7.60 while RNAC 8-day simple moving average is 7.46, which is a Buy signal.
-
The stock price of RNAC is 7.60 while Cartesian Therapeutics, Inc. 20-day SMA is 6.93, which makes it a Buy.
-
Cartesian Therapeutics, Inc. 50-day simple moving average is 7.12 while RNAC share price is 7.60, making it a Buy technically.
-
RNAC stock price is 7.60 and Cartesian Therapeutics, Inc. 200-day simple moving average is 9.23, creating a Sell signal.
RNAC Technical Analysis vs Fundamental Analysis
Sell
28
Cartesian Therapeutics, Inc. (RNAC)
is a Sell
Is Cartesian Therapeutics, Inc. a Buy or a Sell?
-
Cartesian Therapeutics, Inc. stock is rated a SellThe current Cartesian Therapeutics, Inc. [RNAC] share price is $7.60. The Score for RNAC is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
Cartesian Therapeutics, Inc. Stock Info
Market Cap:
197.6M
Price in USD:
7.60
Share Volume:
97.9K
Cartesian Therapeutics, Inc. 52-Week Range
52-Week High:
18.80
52-Week Low:
5.98
Sell
28
Cartesian Therapeutics, Inc. (RNAC)
is a Sell
Cartesian Therapeutics, Inc. Share Price Forecast
-
What is the Cartesian Therapeutics, Inc. stock price today?The Cartesian Therapeutics, Inc. stock price is 7.60 USD today.
-
Will RNAC stock go up or go down?Cartesian Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Cartesian Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cartesian Therapeutics, Inc. is overvalued.
Is Cartesian Therapeutics, Inc. Stock a Buy?
-
Cartesian Therapeutics, Inc. share price is 7.60 while RNAC 8-day exponential moving average is 6.80, which is a Buy signal.
-
The stock price of RNAC is 7.60 while Cartesian Therapeutics, Inc. 20-day EMA is 4.44, which makes it a Buy.
-
Cartesian Therapeutics, Inc. 50-day exponential moving average is 2.24 while RNAC share price is 7.60, making it a Buy technically.
-
RNAC stock price is 7.60 and Cartesian Therapeutics, Inc. 200-day simple moving average is 0.64, creating a Buy signal.
Fundamental Analysis of Cartesian Therapeutics, Inc.
Is Cartesian Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.65 per share, and an increase next year of $0.22 per share.
Technical Analysis of Cartesian Therapeutics, Inc.
Should I short Cartesian Therapeutics, Inc. stock?
-
RNAC Moving Average Covergence Divergence (MACD) indicator is 2.13, suggesting Cartesian Therapeutics, Inc. is a Buy
-
Cartesian Therapeutics, Inc. Relative Strength Index (RSI) is 56.73, which suggest Cartesian Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Cartesian Therapeutics, Inc. is (6.47 - 7.51), which suggest Cartesian Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Cartesian Therapeutics, Inc. is (6.71 - 8.57), which suggest Cartesian Therapeutics, Inc. is a Sell
* Cartesian Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.